Natural killer (NK) cells express receptors that recognize major histocompatibility complex (MHC) class I molecules and regulate cytotoxicity of target cells. In this study, we demonstrate that Ly49A, a prototypical C-type lectin–like receptor expressed on mouse NK cells, requires species-specific determinants on β2-microglobulin (β2m) to recognize its mouse MHC class I ligand, H-2Dd. The involvement of β2m in the interaction between Ly49A and H-2Dd is also demonstrated by the functional effects of a β2m-specific antibody. We also define three residues in α1/α2 and α3 domains of H-2Dd that are critical for the recognition of H-2Dd on target cells by Ly49A. In the crystal structure of the Ly49A/H-2Dd complex, these residues are involved in hydrogen bonding to Ly49A in one of the two potential Ly49A binding sites on H-2Dd. These data unambiguously indicate that the functional effect of Ly49A as an MHC class I–specific NK cell receptor is mediated by binding to a concave region formed by three structural domains of H-2Dd, which partially overlaps the CD8 binding site.
Skip Nav Destination
Article navigation
15 January 2001
Article Contents
Article|
January 08 2001
The Functional Binding Site for the C-Type Lectin–Like Natural Killer Cell Receptor Ly49a Spans Three Domains of Its Major Histocompatibility Complex Class I Ligand
Naoki Matsumoto,
Naoki Matsumoto
aLaboratory of Molecular Medicine, Department of Integrated Biosciences, The University of Tokyo Graduate School of Frontier Sciences, Tokyo 113-0033, Japan
Search for other works by this author on:
Motoaki Mitsuki,
Motoaki Mitsuki
aLaboratory of Molecular Medicine, Department of Integrated Biosciences, The University of Tokyo Graduate School of Frontier Sciences, Tokyo 113-0033, Japan
Search for other works by this author on:
Kyoko Tajima,
Kyoko Tajima
aLaboratory of Molecular Medicine, Department of Integrated Biosciences, The University of Tokyo Graduate School of Frontier Sciences, Tokyo 113-0033, Japan
Search for other works by this author on:
Wayne M. Yokoyama,
Wayne M. Yokoyama
bHoward Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110
Search for other works by this author on:
Kazuo Yamamoto
Kazuo Yamamoto
aLaboratory of Molecular Medicine, Department of Integrated Biosciences, The University of Tokyo Graduate School of Frontier Sciences, Tokyo 113-0033, Japan
Search for other works by this author on:
Naoki Matsumoto
aLaboratory of Molecular Medicine, Department of Integrated Biosciences, The University of Tokyo Graduate School of Frontier Sciences, Tokyo 113-0033, Japan
Motoaki Mitsuki
aLaboratory of Molecular Medicine, Department of Integrated Biosciences, The University of Tokyo Graduate School of Frontier Sciences, Tokyo 113-0033, Japan
Kyoko Tajima
aLaboratory of Molecular Medicine, Department of Integrated Biosciences, The University of Tokyo Graduate School of Frontier Sciences, Tokyo 113-0033, Japan
Wayne M. Yokoyama
bHoward Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110
Kazuo Yamamoto
aLaboratory of Molecular Medicine, Department of Integrated Biosciences, The University of Tokyo Graduate School of Frontier Sciences, Tokyo 113-0033, Japan
Abbreviations used in this paper: ADCC, antibody-dependent cellular cytotoxicity; β2m, β2-microglobulin; CHO, Chinese hamster ovary; MFI, mean fluorescence intensity; sLy49A, soluble Ly49A.
N. Matsumoto and M. Mitsuki contributed equally to this work.
Received:
September 11 2000
Revision Requested:
November 28 2000
Accepted:
December 04 2000
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2001 The Rockefeller University Press
2001
The Rockefeller University Press
J Exp Med (2001) 193 (2): 147–158.
Article history
Received:
September 11 2000
Revision Requested:
November 28 2000
Accepted:
December 04 2000
Citation
Naoki Matsumoto, Motoaki Mitsuki, Kyoko Tajima, Wayne M. Yokoyama, Kazuo Yamamoto; The Functional Binding Site for the C-Type Lectin–Like Natural Killer Cell Receptor Ly49a Spans Three Domains of Its Major Histocompatibility Complex Class I Ligand. J Exp Med 15 January 2001; 193 (2): 147–158. doi: https://doi.org/10.1084/jem.193.2.147
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
